Rapport Therapeutics, Inc. (RAPP)
32.43
+0.05
(+0.15%)
USD |
NASDAQ |
Apr 07, 09:51
Rapport Therapeutics Shareholders Equity (Quarterly) : 484.65M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| EyePoint Plc | 306.11M |
| Praxis Precision Medicines, Inc. | 878.14M |
| Bridgebio Oncology Therapeutics, Inc. | 411.10M |
| Olema Pharmaceuticals, Inc. | 478.56M |
| Arcellx, Inc. | 402.35M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 512.43M |
| Total Liabilities (Quarterly) | 27.78M |
| Debt to Equity Ratio | 0.0237 |
| Current Ratio | 26.17 |
| Net Debt Paydown Yield | -0.14% |